M1412Medical Services

Patients with metastatic nsclc with epidermal growth factor receptor (egfr)

Short description: Met nsclc w/ egfr alk oth ab

Effective date: January 1, 2025
Termination date: —

Related codes (M-series)

M0001Advancing cancer care mvp M0002Opt care kidney hlth mvp M0003Opt care episod neuro mvp M0004Qual care neurologic cnd mvp M0005Value in primary care mvp M0010Eom meos payment M0064Visit for drug monitoring M0075Cellular therapy M0076Prolotherapy M0100Intragastric hypothermia M0201Pne flu hepb cov home admin M0220Tixagev and cilgav inj

Frequently asked questions

What is HCPCS code M1412?

M1412 is a HCPCS Level II code for Patients with metastatic nsclc with epidermal growth factor receptor (egfr).

What category is HCPCS code M1412 in?

M1412 falls under the Medical Services category of HCPCS Level II.

When did HCPCS code M1412 become effective?

M1412 has been effective since January 1, 2025, per CMS's quarterly HCPCS update.

HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.